Fulcrum Therapeutics Inc. (FULC)
NASDAQ: FULC
· Real-Time Price · USD
6.88
0.36 (5.52%)
At close: Aug 22, 2025, 3:59 PM
6.88
0.00%
After-hours: Aug 22, 2025, 04:10 PM EDT
5.52% (1D)
| Bid | 4.98 |
| Market Cap | 372.15M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -73.22M |
| EPS (ttm) | -1.18 |
| PE Ratio (ttm) | -5.83 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 8.44 |
| Volume | 338,889 |
| Avg. Volume (20D) | 687,232 |
| Open | 6.57 |
| Previous Close | 6.52 |
| Day's Range | 6.46 - 6.92 |
| 52-Week Range | 2.31 - 9.90 |
| Beta | 2.47 |
About FULC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FULC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FULC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-2.82%
Fulcrum Therapeutics shares are trading lower foll...
Unlock content with
Pro Subscription
4 weeks ago
+0%
Fulcrum Therapeutics shares are trading higher after the company announced it will present topline results from the 12 mg dose cohort of its Phase 1b PIONEER trial.
